Data / Form D filings / AXOFT, INC.
AXOFT, INC.: Form D filings
AXOFT, INC., a biotechnology company in Cambridge, MA, filed 3 Form D notices with the SEC between 2024 and 2026. The latest, on May 7, 2026, reports $34.2 million sold of a $34.2 million offering to 13 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 148 Sidney St, Cambridge, MA, 02139
- Phone
- (857) 323-6299
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Year incorporated
- 2021
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 2014351
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| May 7, 2026 | New notice | $34,245,399 | $34,245,380 | $19 | 13 | Apr 22, 2026 | sec.gov |
| Mar 5, 2024 | New notice | $9,275,972 | $8,775,976 | $499,996 | 12 | Mar 18, 2022 | sec.gov |
| Mar 5, 2024 | New notice | $5,000,000 | $500,000 | $4,500,000 | 1 | Feb 20, 2024 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Paul Le Floch | Executive Officer, Director | |
| Chia An Lee | Director | |
| Benjamin Pless | Director |
Other biotechnology companies in Massachusetts that filed recently
- Tru Singular Health, Inc. $1 million · Oct 30, 2026
- 511 Therapeutics, Inc. $500,000 · Oct 30, 2026
- Elucid Bioimaging Inc. $56.2 million · Oct 27, 2026
- OrthoIQ, Inc. $1.1 million · Oct 23, 2026
- LeanBio Therapeutics, Inc. offering · Oct 22, 2026
- Quiver Holdings Inc. $3 million · Oct 21, 2026
Every Form D from the week of May 4, 2026 · All recent filings in Massachusetts · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what AXOFT, INC. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.